Search
Search
| Catalog Number | Quantity |
|---|---|
| 455430250 | 25 g |
| 455430010 | 1 g |
| 455430050 | 5 g |
General Information
• Tobramycin is an aminoglycoside compound derived from kanamycin B and displays antibiotic and bacteriostatic activity against gram-negative bacteria
• After entering the cells, it binds irreversibly to a specific aminoglycoside receptor on the bacterial 30S ribosomal subunit and interferes with the initiation complex between messenger RNA and the 30S subunit, consequently inhibiting the protein synthesis process leading to bacterial cell death
• Tobramycin also can interfere with protein elongation since it can induce misreading of the mRNA template, and cause incorrect amino acids to be incorporated into the growing polypeptide chain
Applications
• Due to its activity, tobramycin has been widely applied as a antibiotic
• It has been used to treat pseudomonas aeruginosa infections and is also being investigated for the treatment of sinus infections in vivo animal models
• Tobramycin has been used to study the effect of tobramycin on bacteriophage infected biofilms
Literature References
Meyer, R.; Young, L., Armstrong, D. Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa. Appl Microbiol. 1971, 22, (6), 1147-1151.
Coulter, L.; McLean, R.; Rohde, R.; Aron, G. Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms. Viruses. 2014, 3, 6 (10), 3778-3786.
Vicens, Q.; Westhof, E. Crystal structure of a complex between the aminoglycoside tobramycin and an oligonucleotide containing the ribosomal decoding a site. Chemistry & biology. 2002, 9 (6), 747-755.